Methods for treating mucopolysaccharidosis
US-2024374534-A1 · Nov 14, 2024 · US
US10913729B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10913729-B2 |
| Application number | US-201816181503-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 6, 2018 |
| Priority date | Feb 26, 2015 |
| Publication date | Feb 9, 2021 |
| Grant date | Feb 9, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.
Opening claim text (preview).
The invention claimed is: 1. A mixture comprising one or more compounds of formula (A) and/or salts thereof wherein R 1 is a C 1 -C 15 aliphatic substituent optionally substituted with one or more hydroxyl groups, wherein the aliphatic substituent is saturated or unsaturated, branched or linear, and acyclic or cyclic, provided that if R 1 is an aliphatic substituent with no hydroxyl groups, the one or more compounds of formula (A) is/are selected from cyclohexylcannabidivarinolat, hexylcannabidivarinolat, salts thereof, and a mixture thereof. 2. The mixture according to claim 1 , wherein the aliphatic substituent is saturated and/or linear. 3. The mixture according to claim 1 comprising a compound of formula (A-I) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that at least one of R 1 or R 2 is OH. 4. The mixture according to claim 1 comprising a compound of formula (A-II) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that at least one of R 1 or R 2 is OH. 5. A mixture according to claim 1 comprising a compound of formula (A-III) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that least one of R 1 or R 2 is OH. 6. The mixture according to claim 1 comprising a compound of formula (A-IV) wherein each R 1 is independently H, a C 1 -C 2 alkyl, or OH, and n is an integer from 2 to 10. 7. A mixture according to claim 3 , wherein each R 1 of the compound of formula (A-I) is independently H or OH. 8. A mixture according to claim 4 , wherein each R 1 of the compound of formula (A-II) is independently H or OH. 9. A mixture according to claim 5 , wherein each R 1 of the compound of formula (A-III) is independently H or OH. 10. A mixture according to claim 6 , wherein each R 1 of the compound of formula (A-IV) is independently H or OH. 11. A mixture according to claim 1 , wherein the compound of the formula (A) is a compound of formula (IV): 12. A method for producing a mixture according to claim 1 comprising: reacting an ester of the formula (IX) wherein Y is an organic substituent, with an alcohol of the formula HO—X, wherein X is a C 1 -C 15 aliphatic substituent optionally substituted with one or more hydroxyl groups, wherein the aliphatic substituent is saturated or unsaturated, branched or linear, and acyclic or cyclic, provided that if X is an aliphatic substituent with no hydroxyl groups, the alcohol of formula HO-X is selected from cyclohexanol and hexanol; wherein Y is different from X and selected such that the alcohol of formula HO—Y formed during the reaction boils at 1013 hPa at a lower temperature than the alcohol of formula HO—X. 13. A pharmaceutical or cosmetic formulation comprising a mixture according to claim 1 . 14. A formulation suitable for consumption comprising a mixture according to claim 1 . 15. The mixture according to claim 1 comprising a compound of formula (V) (cannabidivarin, CBDV): and/or a compound of formula (III) ((−)-trans-methylcannabidivarinolat): wherein if the mixture comprises a compound of formula (V), a molar ratio of a total amount of the one or more compounds of formula (A) and/or salts thereof to a total amount of the compound of formula (V) is greater than 1:1, and if the mixture comprises a compound of formula (III), a molar ratio of a total amount of the one or more compounds of formula (A) and/or salts thereof to a total amount of the compound of formula (III) is greater than 1:1.
o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title
of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings · CPC title
having an aromatic ring attached to a carboxyl group · CPC title
by reacting an ester group with a hydroxy group · CPC title
Antihypertensives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.